HB2015, titled the Guaranteeing Individual Fairness in Transplants Act of 2025 or the GIFT Act of 2025, would amend the Social Security Act to bar hospitals from considering a patient’s vaccination status when deciding who should receive an organ transplant. The bill applies to hospitals, critical access hospitals, and rural emergency hospitals participating under Medicare-related provisions of the Social Security Act.
In practical terms, the bill would add a new condition to hospital participation requirements: transplant selection decisions could not take vaccination status into account. The measure is narrowly focused on organ allocation and does not otherwise change transplant eligibility criteria, medical standards, or broader vaccination policy. Its effect would be to preempt hospital-level policies that use vaccination status as one factor in transplant recipient selection.
Impact
The bill would amend Section 1866(a)(1) of the Social Security Act, which governs provider agreements under Medicare, by adding a new prohibition tied to organ transplant selection. If enacted, hospitals and certain rural facilities participating in Medicare would be legally barred from considering vaccination status in determining which individual should receive an organ transplant. The bill would therefore affect hospital compliance obligations and transplant program policies, especially where institutions currently incorporate vaccination status into candidacy or prioritization decisions.
Sentiment
No committee transcripts or recorded votes were provided, so there is no direct evidence of legislative debate or formal support/opposition in the available record. Based on the bill text alone, the measure appears framed as a patient-fairness and anti-discrimination proposal, suggesting supporters would likely emphasize equal access to transplantation regardless of vaccination status. The absence of recorded votes or hearing discussion means overall sentiment cannot be measured from the supplied materials.
Contention
The central point of contention is whether vaccination status is a medically relevant factor that hospitals should be allowed to consider in organ transplant decisions. Supporters are likely to argue that vaccination status should not be used to deny or delay access to life-saving transplants, while opponents may argue that transplant programs should retain discretion to consider vaccination because of post-transplant infection risks and patient outcomes. The bill’s narrow mandate could also raise concerns among hospitals and transplant specialists about federal interference with clinical judgment and organ allocation protocols.